Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy

Diabetic Medicine

Volumn 26, Issue 3, 2009, Pages 240-246

  Bril, V ^a,d   Tomioka, S ^b,c   Buchanan, R A ^b,c   Perkins, B A ^d  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b Dainippon Sumitomo Pharma America Inc   (United States)

^c Dainippon Sumitomo Pharma Ltd   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Clinical score; Diabetic neuropathy; Diagnosis; Modified Toronto Clinical Neuropathy Score; Toronto Clinical Neuropathy Score

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DISEASE DURATION; FEMALE; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYNEUROPATHY; VALIDITY;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; DIABETIC NEUROPATHIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 62449155927     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02667.x     Document Type: Article

References (21)

1. Pfeifer MA, Schumer MP, Gelber DA. Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 1997 46 : S82 89.
2. Brown MJ, Bird SJ, Watling S, Kaleta H, Hayes L, Eckert S et al. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diabetes Care 2004 27 : 1153 1159.
3. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994 17 : 1281 1289.
4. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population. Diabetologia 1993 36 : 150 154.
5. Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the UK: the North-West diabetes foot care study. Diabetes Care 2005 28 : 1869 1875.
6. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997 49 : 229 239.
7. Bril V. NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 1999 41 : 8 13.
8. Valk GD, Nauta JJ, Strijers RL, Bertelsmann FW. Clinical examination vs. neruophysiological examination in the diagnosis of diabetic polyneuropathy. Diabet Med 1992 9 : 716 721.
9. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001 24 : 250 256.
10. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002 25 : 2048 2052.
11. Bril V, Buchanan RA. Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy. Diabetes Care 2004 27 : 2369 2375.
12. Bril V, Buchanan RA. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. Diabetes Care 2006 29 : 68 72.
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. Lancet 1998 352 : 837 853.
14. American Diabetes Association/American Academy of Neurology. Consensus statement: report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 1988 11 : 592 597.
15. Bril V, Ellison R, Ngo M, Bergstrom B, Raynard D, Gin H. Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group. Muscle Nerve 1998 21 : 1368 1373.
16. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951 16 : 297 334.
17. Fleiss, JL. The Design and Analysis of Clinical Experiment. New York : John Wiley & Sons Inc., 1985.
18. Agresti A. An Introduction to Categorical Data Analysis. New York : Wiley, 1996.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 33 : 159 174.
20. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT et al. Distal symmetric polyneuropathy: a definition for clinical research; report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005 64 : 199 207.
21. Greene DA, Arezzo JC, Brown MD, the Zenarestat Study Group. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology 1999 53 : 580 591.